Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
FYB | Xetra | EUR | Delayed | |
FYB | TradeGate | EUR | Delayed | |
FYB | Frankfurt | EUR | Delayed |
Formycon AG develops and markets biosimilar products in Germany and Switzerland. It provides FYB201, a biosimilar candidate for Lucentis, an ophthalmic drug used in the treatment of neovascular age-related macular degeneration and other serious retinal diseases, including diabetic macular edema and myopic choroidal neovascularization under the Ranivisio, ONGAVIA, and CIMERLI names. The company’s pipeline includes FYB202, a biosimilar candidate for Stelara, a biopharmaceutical used in the treatment of chronic inflammatory diseases, such as moderate to severe psoriasis, as well as for the treatment of Crohn's disease and ulcerative colitis, which has completed the Phase III clinical trial; and FYB203, a biosimilar candidate for Eylea, that treats neovascular age-related macular degeneration and serious retinal diseases that is in Phase III clinical trials. It is also developing FYB206, a biosimilar candidate for Keytruda, for the treatment of cancer; and FYB207, a SARS-CoV-2 blocker, an antiviral drug for the treatment of COVID-19. The company was formerly known as Nanohale AG and changed its name to Formycon AG in 2012. Formycon AG was founded in 1999 and is headquartered in Planegg, Germany.
Name | Age | Since | Title |
---|---|---|---|
Peter Wendeln | - | 2010 | Deputy Chairman of Supervisory Board |
Olaf Stiller | 45 | 2010 | Chairman of Supervisory Board |
Johannes Buchner | - | 2016 | Member of Advisory Board |
Gerhard Schaefer | - | 2013 | Member of Advisory Board |
Bernhard Hampl | 73 | 2014 | Member of Advisory Board |
Thomas Siklosi | - | 2018 | Member of Advisory Board |
Klaus Rohrig | - | 2020 | Member of Supervisory Board |
Wolfgang Essler | - | 2023 | Member of the Supervisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review